NGENF
Price
$2.14
Change
+$0.01 (+0.47%)
Updated
Apr 24 closing price
Capitalization
152.23M
TNFA
Price
$0.22
Change
+$0.03 (+15.79%)
Updated
Apr 25, 02:51 PM (EDT)
Capitalization
528.97K
Ad is loading...

NGENF vs TNFA

Header iconNGENF vs TNFA Comparison
Open Charts NGENF vs TNFABanner chart's image
NervGen Pharma
Price$2.14
Change+$0.01 (+0.47%)
Volume$51.91K
Capitalization152.23M
TNF Pharmaceuticals
Price$0.22
Change+$0.03 (+15.79%)
Volume$7.59K
Capitalization528.97K
NGENF vs TNFA Comparison Chart
Loading...
NGENF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NGENF vs. TNFA commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NGENF is a StrongBuy and TNFA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (NGENF: $2.14 vs. TNFA: $0.19)
Brand notoriety: NGENF and TNFA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NGENF: 76% vs. TNFA: 88%
Market capitalization -- NGENF: $152.23M vs. TNFA: $528.97K
NGENF [@Biotechnology] is valued at $152.23M. TNFA’s [@Biotechnology] market capitalization is $528.97K. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NGENF’s FA Score shows that 0 FA rating(s) are green whileTNFA’s FA Score has 1 green FA rating(s).

  • NGENF’s FA Score: 0 green, 5 red.
  • TNFA’s FA Score: 1 green, 4 red.
According to our system of comparison, NGENF is a better buy in the long-term than TNFA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NGENF’s TA Score shows that 5 TA indicator(s) are bullish while TNFA’s TA Score has 4 bullish TA indicator(s).

  • NGENF’s TA Score: 5 bullish, 5 bearish.
  • TNFA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both NGENF and TNFA are a good buy in the short-term.

Price Growth

NGENF (@Biotechnology) experienced а -0.56% price change this week, while TNFA (@Biotechnology) price change was +4.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.17%. For the same industry, the average monthly price growth was -4.24%, and the average quarterly price growth was -12.55%.

Reported Earning Dates

TNFA is expected to report earnings on Apr 11, 2025.

Industries' Descriptions

@Biotechnology (+7.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NGENF($152M) has a higher market cap than TNFA($529K). NGENF YTD gains are higher at: -1.927 vs. TNFA (-83.304). TNFA has higher annual earnings (EBITDA): -11.38M vs. NGENF (-27.5M). NGENF has more cash in the bank: 21M vs. TNFA (10.6M). TNFA has less debt than NGENF: TNFA (18.3K) vs NGENF (129K). NGENF (0) and TNFA (0) have equivalent revenues.
NGENFTNFANGENF / TNFA
Capitalization152M529K28,733%
EBITDA-27.5M-11.38M242%
Gain YTD-1.927-83.3042%
P/E RatioN/AN/A-
Revenue00-
Total Cash21M10.6M198%
Total Debt129K18.3K705%
FUNDAMENTALS RATINGS
NGENF vs TNFA: Fundamental Ratings
NGENF
TNFA
OUTLOOK RATING
1..100
2768
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
8
Undervalued
PROFIT vs RISK RATING
1..100
42100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
4098
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TNFA's Valuation (8) in the null industry is significantly better than the same rating for NGENF (91). This means that TNFA’s stock grew significantly faster than NGENF’s over the last 12 months.

NGENF's Profit vs Risk Rating (42) in the null industry is somewhat better than the same rating for TNFA (100). This means that NGENF’s stock grew somewhat faster than TNFA’s over the last 12 months.

TNFA's SMR Rating (97) in the null industry is in the same range as NGENF (98). This means that TNFA’s stock grew similarly to NGENF’s over the last 12 months.

NGENF's Price Growth Rating (40) in the null industry is somewhat better than the same rating for TNFA (98). This means that NGENF’s stock grew somewhat faster than TNFA’s over the last 12 months.

NGENF's P/E Growth Rating (100) in the null industry is in the same range as TNFA (100). This means that NGENF’s stock grew similarly to TNFA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NGENFTNFA
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
NGENF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNFA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARTIX30.450.24
+0.79%
Artisan International Investor
JSCVX19.88N/A
N/A
Janus Henderson Small Cap Value T
FEUIX24.74N/A
N/A
Fidelity Advisor Glbl Capital Apprec I
MPLAX13.41N/A
N/A
Praxis International Index A
ELMFX16.12N/A
N/A
Lord Abbett Emerging Markets Equity F

NGENF and

Correlation & Price change

A.I.dvisor tells us that NGENF and CYTK have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NGENF and CYTK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGENF
1D Price
Change %
NGENF100%
+0.38%
CYTK - NGENF
25%
Poorly correlated
+6.13%
IBRX - NGENF
23%
Poorly correlated
N/A
TNFA - NGENF
22%
Poorly correlated
+2.07%
CARM - NGENF
22%
Poorly correlated
-1.24%
ATRA - NGENF
22%
Poorly correlated
+10.14%
More

TNFA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNFA has been loosely correlated with COGT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if TNFA jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNFA
1D Price
Change %
TNFA100%
+2.07%
COGT - TNFA
39%
Loosely correlated
+0.89%
PHAT - TNFA
39%
Loosely correlated
+2.49%
TVGN - TNFA
36%
Loosely correlated
-0.98%
LRMR - TNFA
32%
Poorly correlated
+4.87%
BPMC - TNFA
29%
Poorly correlated
+0.33%
More